Catalog No.
DHD74101
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Mouse
Isotype
IgG2b-kappa
Clonality
Monoclonal
Target
TP103, Dipeptidyl peptidase IV, ADABP, Dipeptidyl peptidase 4, CD26, DPP4, Dipeptidyl peptidase IV soluble form, Dipeptidyl peptidase IV membrane form, DPP IV, ADCP2, Adenosine deaminase complexing protein 2, ADCP-2, T-cell activation antigen CD26
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P27487
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
BT 5/9, SAND-26, CAS: 1403744-56-8
Clone ID
Begelomab
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab, PMID: 32203257
The CoV-2 outbreak: how hematologists could help to fight Covid-19, PMID: 32387301
Begelomab for severe refractory dermatomyositis: A case report, PMID: 33655912
Antibodies to watch in 2016, PMID: 26651519
New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature., PMID:38973782
Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2., PMID:35042653
Begelomab for severe refractory dermatomyositis: A case report., PMID:33655912
The CoV-2 outbreak: how hematologists could help to fight Covid-19., PMID:32387301
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-Begelomab., PMID:32203257
Antibodies to watch in 2016., PMID:26651519